Advanced search
Publication Cover
Current Medical Research and Opinion Volume 22, 2006 - Issue 11
Submit an article Journal homepage
249
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study

R. Andrezina Riga Mental Health Care Centre, Department of Psychiatry, Tvaika Street 2, Riga, LV‐1005, LatviaCorrespondence[email protected]
,
R. N. Marcus Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492, USA
,
D. A. Oren Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492, USA
,
G. Manos Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492, USA
,
E. Stock Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492, USA
,
W. H. Carson Otsuka America Pharmaceutical Inc., 100 Overlook Drive, Princeton, NJ 08540, USA
&
R. D. McQuade Otsuka America Pharmaceutical Inc., 100 Overlook Drive, Princeton, NJ 08540, USA
 show all
Pages 2209-2219 | Accepted 19 Sep 2006, Published online: 06 Oct 2006

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Marina Garriga, Isabella Pacchiarotti, Siegfried Kasper, Scott L. Zeller, Michael H. Allen, Gustavo Vázquez, Leonardo Baldaçara, Luis San, R. Hamish McAllister-Williams, Konstantinos N. Fountoulakis, Philippe Courtet, Dieter Naber, Esther W. Chan, Andrea Fagiolini, Hans Jürgen Möller, Heinz Grunze, Pierre Michel Llorca, Richard L. Jaffe, Lakshmi N. Yatham, Diego Hidalgo-Mazzei, Marc Passamar, Thomas Messer, Miquel Bernardo & Eduard Vieta. (2016) Assessment and management of agitation in psychiatry: Expert consensus. The World Journal of Biological Psychiatry 17:2, pages 86-128.
Read now
Domingo Gonzalez, Markus Bienroth, Vivienne Curtis, Matthew Debenham, Stuart Jones, Didier Pitsi & Mohan George. (2013) Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Current Medical Research and Opinion 29:3, pages 241-250.
Read now
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Florence Thibaut & Hans-Jürgen Möller. (2012) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. The World Journal of Biological Psychiatry 13:5, pages 318-378.
Read now
Eva Lindström, Jonas Eberhard, Björn M. Fors, Karina Hansen & Christophe Sapin. (2011) A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden. Nordic Journal of Psychiatry 65:6, pages 403-413.
Read now
Min-Hyeon Park, Changsu Han, Chi-Un Pae, Soo-Jung Lee, Ashwin A Patkar, Praksh S Masand & Wolfgang W Fleischhacker. (2011) Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment. Expert Review of Neurotherapeutics 11:11, pages 1541-1552.
Read now
Andrea Fagiolini, Maria Nitti, Rocco N Forgione, Francesco S Marra & Francesco Casamassima. (2011) Aripiprazole for the treatment of bipolar disorder: a review of current evidence. Expert Opinion on Pharmacotherapy 12:3, pages 473-488.
Read now
Andrea Fagiolini. (2008) Practical guidance for prescribing with aripiprazole in bipolar disorder. Current Medical Research and Opinion 24:9, pages 2691-2702.
Read now

Articles from other publishers (26)

Giovanni Martinotti, Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Mauro Pettorruso, Valentin Skryabin, Stefano L. Sensi & Massimo Di Giannantonio. (2022) Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice. Current Pharmaceutical Design 28:27, pages 2241-2259.
Crossref
Thomas Messer & Frank G. Pajonk. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 45 .
Thomas Messer & Frank G. Pajonk. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 3889 3933 .
Alexia E. Koukopoulos, Lavinia De Chiara & Georgios D. Kotzalidis. 2021. Empathy, Normalization and De-escalation. Empathy, Normalization and De-escalation 93 112 .
Evelien Spelten, Brodie Thomas, Peter F O'Meara, Brian J Maguire, Deirdre FitzGerald & Stephen J Begg. (2020) Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates. Cochrane Database of Systematic Reviews.
Crossref
Maarten Bak, Irene Weltens, Chris Bervoets, Jürgen De Fruyt, Jerzy Samochowiec, Andrea Fiorillo, Gaia Sampogna, Przemyslaw Bienkowski, W. Ulrich Preuss, Blazej Misiak, Dorota Frydecka, Agnieszka Samochowiec, Emma Bak, Marjan Drukker & Geert Dom. (2019) The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis. European Psychiatry 57, pages 78-100.
Crossref
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
Antoni Benabarre, Jose Antonio Campos, Felicia Russo, Giancarlo Cerveri, Davide Prestia, Sergio González, Agustín Pérez-Sendino & Luis Gutiérrez-Rojas. (2018) Tratamiento con aripiprazol en la práctica clínica: consenso de un panel de expertos. Psiquiatría Biológica 25:3, pages 89-95.
Crossref
Edoardo G Ostinelli, Salwan Jajawi, Styliani Spyridi, Kamlaj Sayal & Mahesh B Jayaram. (2018) Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database of Systematic Reviews 2018:1.
Crossref
Peter SturmeyLaurette E. Goedhard & Eibert R. Heerdink. 2017. The Wiley Handbook of Violence and Aggression. The Wiley Handbook of Violence and Aggression 1 15 .
Edoardo G Ostinelli, Melanie J Brooke-Powney, Xue Li & Clive E Adams. (2017) Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database of Systematic Reviews 2017:7.
Crossref
Leslie Citrome & Jan Volavka. (2014) The psychopharmacology of violence: making sensible decisions. CNS Spectrums 19:5, pages 411-418.
Crossref
D. G. Cunningham Owens. 2014. A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs. A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs 35 224 .
T. Charpeaud, L. Samalin & P.-M. Llorca. (2014) Efficacité de l’aripiprazole dans le traitement de la schizophrénie : quelle dose pour quel effet ?. L'Encéphale 40:1, pages 62-73.
Crossref
Robert I. Simon & Kenneth TardiffL. Citrome. 2014. Valutazione e gestione della violenza. Valutazione e gestione della violenza 271 289 .
Clive E Adams, Hanna Bergman, Claire B Irving & Stephen Lawrie. (2013) Haloperidol versus placebo for schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Melanie J Powney, Clive E Adams & Hannah Jones. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Stefano Comai, Michael Tau, Zoran Pavlovic & Gabriella Gobbi. (2012) The Psychopharmacology of Aggressive Behavior. Journal of Clinical Psychopharmacology 32:2, pages 237-260.
Crossref
Jamie D. Croxtall. (2012) Aripiprazole. CNS Drugs 26:2, pages 155-183.
Crossref
Gianluca Airoldi. (2010) Efficacia e tossicità della terapia farmacologica per il controllo del paziente acutamente agitato (II parte). Italian Journal of Medicine 4:3, pages 192-200.
Crossref
Louise Kao, Gregory P. Moore & Kenneth Jackimczyk. 2010. Rosen's Emergency Medicine – Concepts and Clinical Practice. Rosen's Emergency Medicine – Concepts and Clinical Practice 2440 2447 .
Jayanti Bhattacharjee & Hany G El-Sayeh. (2008) Aripiprazole versus typical antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews 2014:7.
Crossref
Dan L Zimbroff. (2008) Pharmacological Control of Acute Agitation. CNS Drugs 22:3, pages 199-212.
Crossref
Fernando Cañas. (2007) Management of agitation in the acute psychotic patient — Efficacy without excessive sedation. European Neuropsychopharmacology 17, pages S108-S114.
Crossref
Claire B Irving, Clive E Adams & Stephen Lawrie. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.